Abstract:A novel strategy was purposed to sustainedly deliver drug-loaded nanoparticles (NPs) to tumor sites and further enhance intracellular drug release. NPs with the ability of sequential self-gelation and self-release in response to a tumor-specific microenvironment were developed, which involved the conjugation of doxorubicin (DOX) on a thermosensitive amphiphilic copolymer (poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone), PCEC) via acid-cleavable hydrazone linkages. The conjugate (PCEC-co-DOX) can self-assemble into micelle-like NPs in water. Moreover, the freeze-dried PCEC-co-DOX NP powder with good dispersibility in water can easily be constructed into an injectable NP aqueous dispersion at ambient temperature, making it convenient for storage and clinical applications. After injection, the dispersion can in situ thermosensitively self-gelate, anchoring large amounts of NPs at the tumor site. Subsequently, the formed NP self-supported gel can sustainedly release NPs themselves in an acidic tumor microenvironment. The released DOX-co-PCEC NPs were taken up by tumor cells and finally realized in intracellular drug release by the acid-triggered cleavage of the hydrazone bond. Compared with the repeated injection of free DOX, a single peritumoral injection of DOX-co-PCEC NP aqueous dispersion achieved a similar tumor inhibition effect but exhibited lower systemic toxicity. In vivo biodistribution studies indicated that DOX delivered by the DOX-co-PCEC NP hydrogel accumulated mainly in tumor tissue rather than in healthy tissue in mice treated with a single peritumoral injection. These results suggest that the design presented here provides a promising nanomedicine platform for cancer therapy.

Enzyme-catalytic Self-triggered Release of Drug from Nanosystem for Efficient Delivery to Nuclei of Tumor Cells.

ROS-triggered self-accelerating drug release nanosystem with charge conversion for enhanced cancer therapy

Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy

Protein-Gated Upconversion Nanoparticle-Embedded Mesoporous Silica Nanovehicles via Diselenide Linkages for Drug Release Tracking in Real Time and Tumor Chemotherapy

Supramolecular Modular Approach toward Conveniently Constructing and Multifunctioning a pH/Redox Dual-Responsive Drug Delivery Nanoplatform for Improved Cancer Chemotherapy

Ultrasound Triggered Local Sequential Reactive Oxygen Species and Nitric Oxide Release for Enhanced Cerasomal Drug Delivery

Dual-responsive Doxorubicin-Loaded Nanomicelles for Enhanced Cancer Therapy.

Facile Construction of Fluorescent Traceable Prodrug Nanosponges for Tumor Intracellular Ph/hypoxia Dual-Triggered Drug Delivery

A dual-amplified ROS-responsive nanosystem with self-accelerating drug release for synergistic chemotherapy.

A Procedurally Activatable Nanoplatform for Chemo/chemodynamic Synergistic Therapy

Core-crosslinked Polyprodrug Nanoparticles Via Facile Crosslinking-Induced Self-Assembly for Tumor Intracellular Acid-Triggered Doxorubicin Delivery

A positive feedback strategy for enhanced chemotherapy based on ROS-triggered self-accelerating drug release nanosystem

Enzyme-Induced and Tumor-Targeted Drug Delivery System Based on Multifunctional Mesoporous Silica Nanoparticles

Reactive oxygen species-responsive amino acid-based polymeric nanovehicles for tumor-selective anticancer drug delivery

Enzyme-/Redox-Responsive Mesoporous Silica Nanoparticles Based on Functionalized Dopamine As Nanocarriers for Cancer Therapy

Light-activated drug release from a hyaluronic acid targeted nanoconjugate for cancer therapy.

Multifunctional Peptide-Amphiphile End-Capped Mesoporous Silica Nanoparticles for Tumor Targeting Drug Delivery

Ph/gsh-Dual-sensitive Hollow Mesoporous Silica Nanoparticle-Based Drug Delivery System for Targeted Cancer Therapy

A Novel, Self-Distinguished, Dual Stimulus-Responsive Therapeutic Nanoplatform for Intracellular On-Demand Drug Release.

Tailored Design of an ROS-Responsive Drug Release Platform for Enhanced Tumor Therapy Via “sequential Induced Activation Processes”

Sequential thermo-induced self-gelation and acid-triggered self-release process of drug-conjugated nanoparticles: A strategy for the sustained and controlled drug delivery to tumors